{"id":94844,"date":"2024-12-05T08:00:20","date_gmt":"2024-12-05T07:00:20","guid":{"rendered":"https:\/\/www.formycon.com\/?p=94844"},"modified":"2025-03-20T17:54:20","modified_gmt":"2025-03-20T16:54:20","slug":"growth-and-future-of-biotechnology-opportunities-through-biosimilars","status":"publish","type":"post","link":"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/","title":{"rendered":"Growth and future of biotechnology: opportunities through biosimilars"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column column_width_use_pixel=&#8221;yes&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; font_family=&#8221;font-130579&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;279312&#8243; column_width_pixel=&#8221;800&#8243;][vc_custom_heading text_font=&#8221;font-126351&#8243; text_transform=&#8221;uppercase&#8221; sub_lead=&#8221;small&#8221; uncode_shortcode_id=&#8221;156219&#8243; subheading=&#8221;Guest article in the Bio Deutschland Yearbook 2024\/2025 (in German only)&#8221;]<\/p>\n<h2>Growth and future of biotechnology: opportunities through biosimilars<\/h2>\n<p>[\/vc_custom_heading][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;2&#8243; bottom_padding=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;160712&#8243;][vc_column column_width_use_pixel=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;148088&#8243; column_width_pixel=&#8221;800&#8243; css=&#8221;.vc_custom_1729250724356{padding-bottom: -36px !important;}&#8221;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; back_color=&#8221;color-106894&#8243; back_image=&#8221;92382&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;473703&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;639037&#8243; css=&#8221;.vc_custom_1732875122405{padding-top: 30px !important;padding-right: 15px !important;padding-bottom: 30px !important;padding-left: 30px !important;}&#8221;][vc_single_image media=&#8221;93059&#8243; media_width_percent=&#8221;60&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;206363&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;204081&#8243; css=&#8221;.vc_custom_1732874415426{padding-top: 30px !important;padding-right: 30px !important;padding-bottom: 20px !important;padding-left: 15px !important;}&#8221;][vc_column_text uncode_shortcode_id=&#8221;990447&#8243;]<strong>Enno Spillner<\/strong><br \/>\nChief Financial Officer (CEO)<br \/>\nFormycon AG[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_column_text uncode_shortcode_id=&#8221;159488&#8243;]Vor 20 Jahren war die Biotechnologie-Landschaft in Deutschland noch deutlich \u00fcberschaubarer und BIO Deutschland begann als kleine Organisation mit relativ wenigen Mitgliedern aus der klassischen roten Biotechnologie. Wie die Branche, hat sich auch der Verband seitdem stark entwickelt und diversifiziert. Auch Formycon als Biosimilar-Spezialist geh\u00f6rt dazu und leistet seinen Beitrag zu Know-how, Investitionen und Wachstum.<\/p>\n<p>Die Biotechnologie in Deutschland steht heute vor drei gro\u00dfen Herausforderungen: einem hohen Innovationsdruck, steigenden Kosten im Gesundheitssystem und unzureichender Finanzierung der Entwicklung. Es gab in den letzten Jahren bedeutende technologische Durchbr\u00fcche und viele der heute kommerziell international erfolgreichen Produkte basieren auf deutscher Innovationskraft und Technologie.<\/p>\n<p>Fortschritt, Innovationskraft und verbesserte Gesundheitsversorgung f\u00fchren aber auch zu steigenden Kosten im Gesundheitssystem. Eine logische Antwort darauf sind Biosimilars, die wir bei Formycon entwickeln. Diese biopharmazeutischen Nachfolgeprodukte erm\u00f6glichen es, hochwirksame Behandlungen zu deutlich niedrigeren Kosten anzubieten, was sowohl den Patienten als auch den Gesundheitssystemen zugutekommt. Die Bedeutung von Biosimilars w\u00e4chst rasant und wird in den n\u00e4chsten Jahren immer entscheidender, um den Zugang zu wirksamen Therapien zu verbessern und diese bezahlbar zu machen.<\/p>\n<p>Die Entwicklung von Biosimilars ist komplex und erfordert jahrelange Forschung sowie hohe Investitionen bis zu ihrer Zulassung. Eine gro\u00dfe technische und analytische Kompetenz sowie wissenschaftliche und regulatorische Expertise sind notwendig, um diesen Prozess erfolgreich zu meistern. Trotz der hohen Entwicklungskosten profitieren Biosimilar-Entwickler nicht von Exklusivit\u00e4tsrechten, was den Margendruck erh\u00f6ht. Deshalb m\u00fcssen diese Unternehmen besonders effizient arbeiten, um im direkten Wettbewerb bestehen zu k\u00f6nnen. In einem Umfeld, in dem es keinen Patentschutz gibt, z\u00e4hlt jeder Tag und jeder Euro.<\/p>\n<p>Der Erfolg eines Biosimilar-Unternehmens und insbesondere von Formycon basiert auf einem erfahrenen Entwickler-Team und einer klaren strategischen Planung bei der Auswahl der Kandidaten. Die enge Abstimmung zwischen Forschung, Entwicklung, Regulatorik und Vermarktung ist entscheidend, um ein Biosimilar erfolgreich auf den Markt bringen zu k\u00f6nnen. Bei Formycon haben wir gezeigt, wie wichtig es ist, auf die richtige Kombination aus Know-how und Erfahrung zu setzen. Unser Team hat sich in den letzten f\u00fcnf Jahren auf rund 240 Mitarbeitende verdoppelt und wir haben all unsere geplanten Meilensteine erreicht: darunter die Zulassung und erfolgreiche Markteinf\u00fchrung unseres ersten Biosimilars in globalen Schl\u00fcsselm\u00e4rkten sowie Zulassungen der FDA und EC f\u00fcr weitere Biosimilars in diesem Jahr.<\/p>\n<p>F\u00fcr Formycon ist die Auswahl der Partner \u2013 vor allem in den Bereichen Herstellung und Vermarktung \u2013 in diesem intensiven Wettbewerbsumfeld extrem wichtig, um Marktanteile und Margen zu sichern und den Markt mit hochqualitativen Biosimilars zu durchdringen. Die erfolgreiche Vermarktung und daraus resultierende Produktums\u00e4tze sichern in den n\u00e4chsten Jahren einen Teil der Investitionen in unsere vielversprechende und diverse Pipeline von Biosimilars der n\u00e4chsten Generation, wie z. B. f\u00fcr die dieses Jahr gestartete Entwicklung von Pembrolizumab.<\/p>\n<p>Unser Erfolg basiert auf einer Mischung aus wissenschaftlicher Expertise, Marktintelligenz, Agilit\u00e4t, Flexibilit\u00e4t und Kostensensitivit\u00e4t, um im hart umk\u00e4mpften Biosimilar-Markt zu wachsen und langfristig zu bestehen. Dies gilt auch f\u00fcr die deutsche Biotechnologie-Branche, die einem starken internationalen Wettbewerb ausgesetzt ist. Umso wichtiger ist die Arbeit von BIO Deutschland, die Interessen zu b\u00fcndeln und sich f\u00fcr besser Rahmenbedingungen sowie Unterst\u00fctzung in Politik und \u00d6ffentlichkeit einzusetzen. Biotech ist Zukunftstechnologie, die auch in den n\u00e4chsten 20 Jahren Innovationen vorantreiben wird, um die Herausforderungen der Gesundheitssysteme zu meistern.[\/vc_column_text][vc_empty_space empty_h=&#8221;1&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;2&#8243; bottom_padding=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;160712&#8243;][vc_column column_width_use_pixel=&#8221;yes&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;180165&#8243; column_width_pixel=&#8221;800&#8243; css=&#8221;.vc_custom_1729504305950{padding-bottom: -36px !important;}&#8221;][vc_separator sep_color=&#8221;color-jevc&#8221; uncode_shortcode_id=&#8221;126413&#8243; sep_color_type=&#8221;uncode-palette&#8221; el_height=&#8221;1px&#8221;][vc_column_text uncode_shortcode_id=&#8221;862029&#8243;]The complete <strong>Bio Deutschland Yearbook<\/strong> is available for\u00a0<strong><a href=\"https:\/\/www.biodeutschland.org\/de\/jahrbuecher.html\" target=\"_blank\" rel=\"noopener\">Download<\/a><\/strong> here[\/vc_column_text][vc_separator sep_color=&#8221;color-jevc&#8221; uncode_shortcode_id=&#8221;126413&#8243; sep_color_type=&#8221;uncode-palette&#8221; el_height=&#8221;1px&#8221;][vc_empty_space empty_h=&#8221;1&#8243;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column column_width_use_pixel=&#8221;yes&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; font_family=&#8221;font-130579&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;279312&#8243; column_width_pixel=&#8221;800&#8243;][vc_custom_heading text_font=&#8221;font-126351&#8243; text_transform=&#8221;uppercase&#8221; sub_lead=&#8221;small&#8221; uncode_shortcode_id=&#8221;156219&#8243; subheading=&#8221;Guest [&hellip;]<\/p>\n","protected":false},"author":23,"featured_media":92392,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[],"tags":[],"class_list":["post-94844","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Growth and future of biotechnology: opportunities through biosimilars - Formycon AG<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Growth and future of biotechnology: opportunities through biosimilars - Formycon AG\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column column_width_use_pixel=&#8221;yes&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; font_family=&#8221;font-130579&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;279312&#8243; column_width_pixel=&#8221;800&#8243;][vc_custom_heading text_font=&#8221;font-126351&#8243; text_transform=&#8221;uppercase&#8221; sub_lead=&#8221;small&#8221; uncode_shortcode_id=&#8221;156219&#8243; subheading=&#8221;Guest [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/\" \/>\n<meta property=\"og:site_name\" content=\"Formycon AG\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-05T07:00:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-20T16:54:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/10\/Formycon_6893_1200x700.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Formycon AG\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TLadda\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Formycon AG\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/\",\"url\":\"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/\",\"name\":\"Growth and future of biotechnology: opportunities through biosimilars - Formycon AG\",\"isPartOf\":{\"@id\":\"https:\/\/www.formycon.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/10\/Formycon_6893_1200x700.jpg\",\"datePublished\":\"2024-12-05T07:00:20+00:00\",\"dateModified\":\"2025-03-20T16:54:20+00:00\",\"author\":{\"@id\":\"https:\/\/www.formycon.com\/en\/#\/schema\/person\/7449881f67d34cc4aa6e4f1871bb5c5f\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/#breadcrumb\"},\"inLanguage\":\"en\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en\",\"@id\":\"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/#primaryimage\",\"url\":\"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/10\/Formycon_6893_1200x700.jpg\",\"contentUrl\":\"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/10\/Formycon_6893_1200x700.jpg\",\"width\":1200,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.formycon.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Growth and future of biotechnology: opportunities through biosimilars\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.formycon.com\/en\/#website\",\"url\":\"https:\/\/www.formycon.com\/en\/\",\"name\":\"Formycon AG\",\"description\":\"Global Quality Biosimilars\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.formycon.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.formycon.com\/en\/#\/schema\/person\/7449881f67d34cc4aa6e4f1871bb5c5f\",\"name\":\"Formycon AG\",\"sameAs\":[\"https:\/\/x.com\/TLadda\"],\"url\":\"https:\/\/www.formycon.com\/en\/blog\/author\/tladda\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Growth and future of biotechnology: opportunities through biosimilars - Formycon AG","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/","og_locale":"en_US","og_type":"article","og_title":"Growth and future of biotechnology: opportunities through biosimilars - Formycon AG","og_description":"[vc_row][vc_column column_width_use_pixel=&#8221;yes&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; font_family=&#8221;font-130579&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;279312&#8243; column_width_pixel=&#8221;800&#8243;][vc_custom_heading text_font=&#8221;font-126351&#8243; text_transform=&#8221;uppercase&#8221; sub_lead=&#8221;small&#8221; uncode_shortcode_id=&#8221;156219&#8243; subheading=&#8221;Guest [&hellip;]","og_url":"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/","og_site_name":"Formycon AG","article_published_time":"2024-12-05T07:00:20+00:00","article_modified_time":"2025-03-20T16:54:20+00:00","og_image":[{"width":1200,"height":700,"url":"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/10\/Formycon_6893_1200x700.jpg","type":"image\/jpeg"}],"author":"Formycon AG","twitter_card":"summary_large_image","twitter_creator":"@TLadda","twitter_misc":{"Written by":"Formycon AG","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/","url":"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/","name":"Growth and future of biotechnology: opportunities through biosimilars - Formycon AG","isPartOf":{"@id":"https:\/\/www.formycon.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/#primaryimage"},"image":{"@id":"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/#primaryimage"},"thumbnailUrl":"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/10\/Formycon_6893_1200x700.jpg","datePublished":"2024-12-05T07:00:20+00:00","dateModified":"2025-03-20T16:54:20+00:00","author":{"@id":"https:\/\/www.formycon.com\/en\/#\/schema\/person\/7449881f67d34cc4aa6e4f1871bb5c5f"},"breadcrumb":{"@id":"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/#breadcrumb"},"inLanguage":"en","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/"]}]},{"@type":"ImageObject","inLanguage":"en","@id":"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/#primaryimage","url":"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/10\/Formycon_6893_1200x700.jpg","contentUrl":"https:\/\/www.formycon.com\/wp-content\/uploads\/2024\/10\/Formycon_6893_1200x700.jpg","width":1200,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.formycon.com\/en\/blog\/2024\/12\/05\/growth-and-future-of-biotechnology-opportunities-through-biosimilars\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.formycon.com\/en\/"},{"@type":"ListItem","position":2,"name":"Growth and future of biotechnology: opportunities through biosimilars"}]},{"@type":"WebSite","@id":"https:\/\/www.formycon.com\/en\/#website","url":"https:\/\/www.formycon.com\/en\/","name":"Formycon AG","description":"Global Quality Biosimilars","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.formycon.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en"},{"@type":"Person","@id":"https:\/\/www.formycon.com\/en\/#\/schema\/person\/7449881f67d34cc4aa6e4f1871bb5c5f","name":"Formycon AG","sameAs":["https:\/\/x.com\/TLadda"],"url":"https:\/\/www.formycon.com\/en\/blog\/author\/tladda\/"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-11 02:52:13","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/posts\/94844","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/comments?post=94844"}],"version-history":[{"count":19,"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/posts\/94844\/revisions"}],"predecessor-version":[{"id":94900,"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/posts\/94844\/revisions\/94900"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/media\/92392"}],"wp:attachment":[{"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/media?parent=94844"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/categories?post=94844"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.formycon.com\/en\/wp-json\/wp\/v2\/tags?post=94844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}